Anesthesia for percutaneous closure of atrial septal defects
Conditions
Interventions
D-R group:dexmedetomidine combined with remifentanil
P-R group:propofol combined with remifentanil are
Sponsors
Fujian Medical University Union Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: Patients with secundum atrial septal defects (ASD);Left-to-right intracardiac shunt; aged >=18 years old; American society of anesthesiologists(ASA)class <IV.
Exclusion criteria
Exclusion criteria: Coexisting other cardiovascular malformations; Bi-directional or right-to-left intracardiac shunt; STOP-Bang score >=3; Heart rate 100 beats/min; Other known severe arrhythmias; Severe renal, hepatic, or heart failure; Known drug allergies; A history of drug abuse; incapable of communicate
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The incidence of adverse events;the outcome of arterial blood gas analysis;induction time and recovery time;Pain level; | — |
Secondary
| Measure | Time frame |
|---|---|
| Patients' and physicians' satisfaction of sedation; | — |
Countries
China
Contacts
Public ContactGuican Zhang
Fujian Medical University Union Hospital
Outcome results
None listed